April 2024

Intra-Cellular Therapies

Intra-Cellular Therapies

Co-Manager (Follow-On)

Canaccord Genuity Acts as Co-Manager to Intra-Cellular Therapies on its US$575,000,049 Follow-On Offering

More Like This

February 2025

Exploristics

Exclusive Financial Advisor to Exploristics on its Acquisition by MMS Holdings
US$21m

February 2025

Neuronetics

Sole Bookrunner (Follow-On Offering)
February 2025

Jabil

Exclusive Financial Advisor to Jabil on its Acquisition of Pharmaceutics International

View all Healthcare transactions